611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
CDC Updates Zika Guidance for Infant CareHealth Tip: Recognize Symptoms of Latex AllergyExercising With Asthma or AllergiesCan Aspirin Stop Liver Cancer in Hepatitis B Patients?Pollution Tied to 9 Million Deaths Worldwide in 2015Health Tip: Protect Yourself Against Breast CancerSkip Opioid Treatment for Migraine in the ERPPI Use Linked to Increased Risk of Ischemic Stroke, MINew Genes Linked to Restless Legs SyndromeAvoiding Alcohol Helps the Heart Beat Better2 Million Americans May Have Arsenic in Their Well WaterFirefighters Exposed to Carcinogens Through the SkinNewer Blood Thinners May Not Bring Higher Bleeding RiskScoliosis Screenings Can Help Catch Spine Problem EarlyArthritis Can Strike ChildrenHealth Tip: Relieve Ear Pressure While FlyingBlack Children Missing Out on Eczema TreatmentNew Framework Guides Tx Decisions for Atopic DermatitisHealth Tip: Recognizing SepsisAround the World, Too Little Relief for PainNearly 4 in 10 U.S. Adults Now ObeseFDA Panel Supports Gene Therapy for Kids With Rare Eye Disease30-Day Mortality Lower With Female SurgeonsDirect Primary Care May Fill Niche for Uninsured3 Factors That Could Raise Your Risk of Bloodstream InfectionStroke Risk Factors Are RisingTwo Ebola Vaccines Spur Lasting Immune ResponseHormone Therapy May Be OK for Women With MigrainesMigraine MattersMedial Temporal Lobe Surgery Linked to Prevalence of TinnitusHigher Levels of Fungus ID'd in Patients With Crohn'sWhere There's Type 1 Diabetes, Celiac Disease May FollowAntibiotic Use Not Linked to Islet, Celiac Disease AutoimmunitySome U.S. Olympians Got West Nile in Brazil, But Not ZikaPenicillin Misconceptions May Raise Post-Op Infection RiskHate UTIs? One Simple Step Can Cut the RiskIDSA: Retail Meat May Be a Transmission Source for UTIsLonger Anesthesia Duration Tied to More Surgical ComplicationsFirst Test to Detect Zika in Blood Donations ApprovedHealth Tip: Learn Symptoms of Childhood SinusitisLimiting 'Cold Time' Could Make More Organs Available for TransplantHealth Literacy Linked to Length of Stay After Abdominal SurgeryZika Vaccine Works in Early Human TrialHealth Tip: Understanding Loud Noise and Hearing LossAllergy Relief Do's and Don'tsPatient Factors Differ for Surgical, All-Cause ReadmissionComing Soon: A Faster Test for Antibiotics Against UTIs?Antibody Injections in Pregnancy Might Shield Fetus From ZikaHealth Tip: Giving BloodMore U.S. Measles Cases From No Vaccine vs. Imported Disease
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

CPAP Doesn't Alter Renal Function in Coexisting OSA, CVD


HealthDay News
Updated: Aug 11th 2017

new article illustration

FRIDAY, Aug. 11, 2017 (HealthDay News) -- For individuals with coexisting obstructive sleep apnea (OSA) and cardiovascular disease, continuous positive airway pressure (CPAP) does not alter renal function, according to a study published online July 25 in the American Journal of Respiratory and Critical Care Medicine.

Kelly A. Loffler, Ph.D., from Flinders University in Daw Park, Australia, and colleagues examined the effects of CPAP on renal function in individuals with coexisting OSA and cardiovascular disease in a substudy of the international Sleep Apnea and Cardiovascular Endpoints trial. Renal function and adverse events were compared between 102 CPAP treated and 98 usual-care treated patients.

The researchers found that after a median period of 4.4 years, the median change in estimated glomerular filtration rate did not differ significantly between the CPAP and usual-care groups. No between-group differences were seen in the end-of-study urinary albumin:creatinine ratio or the occurrence of serious renal or urinary adverse events. The findings were not influenced by the level of CPAP adherence.

"CPAP treatment of OSA in patients with cardiovascular disease does not alter renal function, nor the occurrence of renal adverse events," the authors write.

Respironics Sleep and Philips Respironics provided funding for the trial.

Abstract
Full Text (subscription or payment may be required)